[go: up one dir, main page]

NO951740L - Preparater av eikebarkekstrakt, beslektede syntetiske preparater og fremgangsmåte for anvendelse av disse - Google Patents

Preparater av eikebarkekstrakt, beslektede syntetiske preparater og fremgangsmåte for anvendelse av disse

Info

Publication number
NO951740L
NO951740L NO951740A NO951740A NO951740L NO 951740 L NO951740 L NO 951740L NO 951740 A NO951740 A NO 951740A NO 951740 A NO951740 A NO 951740A NO 951740 L NO951740 L NO 951740L
Authority
NO
Norway
Prior art keywords
oak bark
preparations
bark extract
ions
methods
Prior art date
Application number
NO951740A
Other languages
English (en)
Other versions
NO951740D0 (no
Inventor
David N S Hon
Thomas R Stanley
Original Assignee
H E Stanley Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H E Stanley Pharmaceuticals filed Critical H E Stanley Pharmaceuticals
Publication of NO951740D0 publication Critical patent/NO951740D0/no
Publication of NO951740L publication Critical patent/NO951740L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Laminated Bodies (AREA)
  • Road Paving Structures (AREA)

Abstract

Høyere konsentrasjoner av eikebarkaske-ekstrakt, dvs. høyere enn 20 vekt-*, er nyttig for behandling av hudkreft. Lavere konsentrasjoner av eikebarkekstrakt har l tillegg terapeutiske egenskaper som hittil Ikke har vært erkjent. For eksempel er preparater Inne- holdende 40-80 % eikebarkekstrakt nyttige ved be- handling av akutte canserøse hudsår. I tillegg tilvelebrlnger syntetiske blandinger inneholdende kaliumioner, slnkloner, kalsiumloner mange av de samme fordelaktige egenskapene som eikebarkekstrakt. Innbefatnlng av rubidlumioner og svovel er også fordelaktig for visse anvendelser.
NO951740A 1992-11-06 1995-05-04 Preparater av eikebarkekstrakt, beslektede syntetiske preparater og fremgangsmåte for anvendelse av disse NO951740L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97307192A 1992-11-06 1992-11-06
PCT/US1993/010670 WO1994011010A2 (en) 1992-11-06 1993-11-04 Compositions of oak bark extract, related synthetic compositions, and method of using same

Publications (2)

Publication Number Publication Date
NO951740D0 NO951740D0 (no) 1995-05-04
NO951740L true NO951740L (no) 1995-06-19

Family

ID=25520460

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951740A NO951740L (no) 1992-11-06 1995-05-04 Preparater av eikebarkekstrakt, beslektede syntetiske preparater og fremgangsmåte for anvendelse av disse

Country Status (21)

Country Link
US (1) US6149947A (no)
EP (1) EP0668769B1 (no)
JP (1) JP3640215B2 (no)
AT (1) ATE191850T1 (no)
AU (1) AU700019B2 (no)
BR (1) BR9307401A (no)
CA (1) CA2148795C (no)
CY (1) CY2231B1 (no)
CZ (1) CZ117395A3 (no)
DE (1) DE69328438T2 (no)
DK (1) DK0668769T3 (no)
ES (1) ES2147780T3 (no)
HU (1) HUT73791A (no)
MX (1) MX9306960A (no)
NO (1) NO951740L (no)
NZ (1) NZ258019A (no)
OA (1) OA10153A (no)
PL (1) PL308770A1 (no)
PT (1) PT668769E (no)
WO (1) WO1994011010A2 (no)
ZA (1) ZA938274B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7014870B1 (en) * 1992-11-06 2006-03-21 Greystone Medical Group, Inc. Compositions of oak bark extract related synthetic compositions and method of using same
AUPN104895A0 (en) * 1995-02-10 1995-03-09 Lai, John Methods of and preparations for the treatment of ailments and disorders
US20040037898A1 (en) * 1997-10-08 2004-02-26 Hon David N.S Compositions of oak bark extract, related synthetic compositions and method of using same
US20050033251A1 (en) * 1998-12-08 2005-02-10 Quick-Med Technologies, Inc. Controlled release of biologically active substances from select substrates
US20040170703A1 (en) * 2001-11-29 2004-09-02 Greystone Medical Group, Inc. Reduction of reactive oxygen species in chronic wound management
MXPA04005219A (es) * 2001-11-29 2005-06-20 Greystone Medical Group Inc Tratamiento de heridas y composiciones empleadas.
US6667026B1 (en) 2002-03-15 2003-12-23 Pocono Falls, Inc. Allergic contact dermatitis treatment and composition therefor
US20040023937A1 (en) * 2002-05-24 2004-02-05 Greystone Medical Group, Inc. Anti-cancer formulation
CA2511440A1 (en) * 2002-12-23 2004-07-15 Greystone Medical Group, Inc. Reduction of reactive oxygen species in chronic wound management
WO2005000328A1 (en) * 2003-06-24 2005-01-06 Zanti Gianfranco Compositions based on plant ash for the treatment of skin diseases
CA2571314A1 (en) * 2004-06-22 2006-01-05 Greystone Medical Group, Inc. Methods for treatment of wounds using time release compositions
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
JP5038331B2 (ja) 2006-02-03 2012-10-03 ジェイアール ケム エルエルシー 銅と亜鉛の組成物を用いた老化防止治療
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
CA2700990C (en) 2007-03-15 2014-08-12 Om Kataria Uterine stimulant sticks
ES2891548T3 (es) * 2007-10-15 2022-01-28 Hs Pharmaceuticals Llc Composiciones que contienen silicato y métodos de tratamiento
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US20160184354A1 (en) 2009-01-23 2016-06-30 Jr Chem, Llc Rosacea treatments and kits for performing them
US20110200655A1 (en) * 2010-02-16 2011-08-18 Michael Darryl Black Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US8828449B2 (en) 2012-01-26 2014-09-09 Libby Robinson Wound dressing composition and method of use
US9351995B1 (en) 2011-04-29 2016-05-31 Red Oax Holdings, LLC Compositions and methods of enhancing wound healing
US20140249462A1 (en) * 2011-07-20 2014-09-04 3M Innovatative Properties Company Dressing with ion-carrying composition
EP2736486B1 (en) * 2011-07-28 2019-03-06 3M Innovative Properties Company Wound-healing compositions and method of use
JP6697842B2 (ja) 2011-08-17 2020-05-27 スリーエム イノベイティブ プロパティズ カンパニー モノマーグラフト化繊維及びその使用
GB201402672D0 (en) 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
WO2016123539A1 (en) 2015-01-29 2016-08-04 Wardell Mark R Wound healing compositions involving medicinal honey, mineral ions, and methylglyoxal, and methods of use
CA3131796C (en) * 2019-03-04 2023-10-03 Celloryx AG Chloride-inducible prokaryotic expression system
IT201900018047A1 (it) * 2019-10-07 2021-04-07 Nello Vallicella Procedimento per la preparazione di una composizione topica liquida.
WO2024196897A1 (en) * 2023-03-22 2024-09-26 Courtland Imel Novel methods for increasing healing speed of human and animal wounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US256847A (en) * 1882-04-25 Salve
US55911A (en) * 1866-06-26 Improved medical compound
US37901A (en) * 1863-03-17 Improved liniment
US202246A (en) * 1878-04-09 Improvement in medical compounds
DE819127C (de) * 1949-09-28 1951-10-29 Heinz Dr Bauer Verfahren zur Herstellung eines Heilbades gegen Hautekzeme
DE812341C (de) * 1950-03-07 1951-08-27 Penicillin Ges Dauelsberg & Co Verfahren zur Herstellung eines Hautbehandlungsmittels
DE833840C (de) * 1950-06-01 1952-03-13 Dr Heinz Bauer Verfahren zur Herstellung einer Salbe gegen Hautekzeme
US3928584A (en) * 1969-06-30 1975-12-23 Us Health Education & Welfare Extracts from active tree saps for treating P388 mouse leukemia
US4059695A (en) * 1974-02-14 1977-11-22 Kanari Hirosaki Method for manufacturing a tonic composition for man and other animals
JPS60164467A (ja) * 1984-02-07 1985-08-27 Rooman Kogyo:Kk 飲料
EP0217975B1 (de) * 1985-10-08 1991-12-04 Psori-Med Ag Salzmischung zur Behandlung der Schuppenflechte (Psoriasis) und anderer Hautkrankheiten
US4847083A (en) * 1986-04-02 1989-07-11 Dermasciences, Inc. Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith
BE1000950A3 (fr) * 1987-10-05 1989-05-23 Claude Patricia Produit de beaute saliaris au sel de la mer morte et a l'argile verte de haute provence.
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
US5080900A (en) * 1990-04-17 1992-01-14 Stanley R Thomas Treatment of skin ulcers with an aqueous extract of oak bark ash

Also Published As

Publication number Publication date
CY2231B1 (en) 2003-04-18
EP0668769B1 (en) 2000-04-19
WO1994011010A3 (en) 1994-09-15
JPH08503462A (ja) 1996-04-16
DE69328438T2 (de) 2001-01-04
DE69328438D1 (de) 2000-05-25
US6149947A (en) 2000-11-21
CA2148795A1 (en) 1994-05-26
AU5550094A (en) 1994-06-08
NO951740D0 (no) 1995-05-04
WO1994011010A2 (en) 1994-05-26
CZ117395A3 (en) 1995-11-15
ATE191850T1 (de) 2000-05-15
BR9307401A (pt) 1999-08-24
JP3640215B2 (ja) 2005-04-20
HU9501323D0 (en) 1996-05-28
CA2148795C (en) 2004-08-10
ES2147780T3 (es) 2000-10-01
PL308770A1 (en) 1995-08-21
HUT73791A (en) 1996-09-30
OA10153A (en) 1996-12-18
ZA938274B (en) 1994-06-09
EP0668769A1 (en) 1995-08-30
MX9306960A (es) 1995-01-31
PT668769E (pt) 2000-10-31
DK0668769T3 (da) 2000-10-02
NZ258019A (en) 1998-12-23
AU700019B2 (en) 1998-12-17

Similar Documents

Publication Publication Date Title
NO951740D0 (no) Preparater av eikebarkekstrakt, beslektede syntetiske preparater og fremgangsmåte for anvendelse av disse
ES2052871T3 (es) Preparacion de bis (3,5-di-t-butil-4-hidroxifeniltio)metano.
WO1994011010B1 (en) Compositions of oak bark extract, related synthetic compositions, and method of using same
DE10199020I1 (de) Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit
DE69333951D1 (de) Rekombinantes pseudomonas exotoxin mit gesteigerter aktivität
ATE190623T1 (de) Verwendung von steroiden zur inhibierung von angiogenesis
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
EP0325129A3 (en) Disubstituted pyridines
AU553269B2 (en) 2,3-diaryl-5-halo thiophenes
DE59002154D1 (de) Kombinationspraeparate enthaltend rifampicin und thioacetazon sowie gegebenenfalls isonicotinsaeurehydrazid oder ethambutol als aktive wirkstoffe.
ATE78164T1 (de) Verwendung von metalloporphyrin zur umkehr des toxischen effekts der tumortherapie.
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
DE69232852D1 (de) Verwendung von topotecan in der behandlung von nichtkleinzelligen lungenkarzinomen
NZ220495A (en) A2a cyclopeptan-2-ones carrier containing methotrexate compositions
ATE87314T1 (de) Platin-arzneimittel.
DE3485282D1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
ATE214923T1 (de) Verwendung von (r)-verapamil als medizin zur behandlung von angina
AU5199286A (en) New use of 1,4-dihydropyridine derivatives
UA8280A (uk) Спосіб лікування псоріазу